期刊文献+

异基因造血干细胞移植后迟发性非感染性肺部并发症的发生和危险因素分析 被引量:3

The incidence and risk factors of late-onset non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation
原文传递
导出
摘要 目的 分析异基因造血干细胞移植(allo-HSCT)后迟发性非感染性肺部并发症(LONIPC)的发生和危险因素.方法 回顾性分析我院2003年1月至2006年8月144例接受allo-HSCT并存活超过3个月的患者资料,统计LONIPC的发生率,分析其发生的危险因素.结果 144例患者中位随访时间为1149(103~2151)d,其中24例(16.7%)被诊断为LONIPC,发病中位时间为allo-HSCT后235(116~950)d.单因素分析结果显示,LONIPC的发生与巨细胞病毒(CMV)抗原血症(P=0.000)、急性移植物抗宿主病(aGVHD)(P=0.026)、慢性移植物抗宿主病(cGVHD)(P=0.002)显著相关.多因素二分类Logistic回归分析结果显示,LONIPC发生的危险因素为cGVHD(OR=18.804,P=0.004)和CMV抗原血症(OR=14.376,P=0.000).结论 LONIPC是allo-HSCT晚期主要的并发症之一,eGVHD和CMV抗原血症是allo-HSCT后LONIPC发生的相关危险因素. Abstract:Objective To analyze the incidence and the risk factors of late-onset non-infectious pulmonary complications ( LONIPC) after allogeneic hematopoietic stem cell transplantation ( allo-HSCT).Methods Clinical data from 144 patients who underwent allo-HSCT and survived more than 3 months at our institution between January 2003 and August 2006 were collected, and the incidence and its risk factors of LONIPC were reviewed retrospectively.Results With a median follow-up time of 1149 (103 -2151) d, 24 patients (16.7% ) fulfilled the diagnostic criteria for LONIPC.The median time to diagnosis of LONIPC was 235 days after transplantation (range, 116 -950 days).Three variables were associated with LONIPC on uni-variate analysis; CMV antigenaemia (P = 0.000) ,grade Ⅱ - Ⅳ aGVHD (P=0.026) and cGVHD (P = 0.002).By using a Binary Logistic regression model for multivariate analysis, cGVHD( OR = 18.804,P = 0.004) and CMV antigenaemia ( OR = 14.376,P =0.000) were the risk factors of LONIPC.Conclusion LONIPC is one of the major complications after allo-HSCT and cGVHD and CMV antigenaemia are the risk factors for developing LONIPC.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2010年第4期249-252,共4页 Chinese Journal of Hematology
基金 国家自然科学基金(30971300) 广东省科技计划(2009A030200007)
关键词 造血于细胞移植 非感染性肺部并发症 危险因素 Hematopoietic stem cell transplantation Late-onset non-infectious pulmonary complications: Risk factor
  • 相关文献

参考文献15

  • 1Afessa B,Peters SG.Noninfectious pneumonitis after blood and marrow transplant.Curr Opin Oncol,2008,20:227-233.
  • 2Yoshihara S,Yanik G,Cooke KR,et al.Bronchiolitis obliterans syndrome (BOS),bronchiolitis obliterans organizing pneumonia (BOOP),and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant,2007,13:749-759.
  • 3刘启发,孙竞,张钰,徐丹,刘晓力,徐兵,孟凡义,周淑芸.环孢素A+甲氨蝶呤+霉酚酸酯+抗胸腺细胞球蛋白四联方案预防无关供体造血干细胞移植中的移植物抗宿主病[J].第一军医大学学报,2003,23(11):1143-1145. 被引量:17
  • 4Thomas ED,Storb R,Clift RA,et al.Bone marrow transplantation.New Engl J Med,1975,292.895-902.
  • 5Palmas A,Tefferi A,Myers JL,et al.Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation.Br J Haematol,1998,100:680-687.
  • 6Soubani AO,Miller KB,Hassoun PM,et al.Pulmonary complications of bone marrow transplantation.Chest,1996,109; 1066-1077.
  • 7Patriarca F,Skerl C,Sperotto A,et al.Incidence,outcome,and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation.Bone Marrow Transplant,2004,33:751-758.
  • 8Afessa B,Peters SG.Chronic lung disease after hematopoietic stem cell transplantation.Clin Chest Med,2005,26:571-586.
  • 9Roychowdhury M,Pambuccian SE,Asian DL,et al.Pulmonary complications after bone marrow transplantation:an autopsy study from a large transplantation center.Arch Pathol Lab Med,2005,129:366-371.
  • 10Sharma S,Nadrous HF,Peters SG,et al.Pulmonary complications in adult blood and marrow transplant recipients:autopsy findings.Chest,2005,128:1385-1392.

二级参考文献9

  • 1Mattsson J, Ringden O, Aschan J, et al. A low incidence of grade II to IV acute GVHD, but high mortality from infection using HLA-A,-B, and -DR-identical unrelated donors and immunosuppression with ATG, cyclosporine, and methotrexate[J]. Transplant Proc, 1997, 29(1-2): 735-6.
  • 2Kroger N, Zabelina T, Kruger W, et al.Anti-thymocyte-globulin as part of the preparative regimen prevents graft failure and severe graft versus host disease (GvHD) in allogeneic stem cell transplantation from unrelated donors[J]. Ann Hematol, 2001, 80(4): 209-15.
  • 3Nachbaur D, Eibl B, Kropshofer G, et al. In vivo T cell depletion with low-dose rabbit antithymocyte globulin results in low transplant-related mortality and low relapse incidence following unrelated hematopoietic stem cell transplantation[ J]. J Hematother Stem Cell Res, 2002, 11(4): 731-7.
  • 4Duggan P, Booth K, Chaudhry A, et al. Unrelated donor BMT recipients given pretransplant low-dose antithymocyte globulin have outcomes equivalent to matched sibling BMT: a matched pair analysis[ J ]. Bone Marrow Transplant, 2002, 30( 10): 681-6.
  • 5Appelbaum FR, Buckner CD, et al. Regimen-related toxicity in patients undergoing bone marrow transplantation [J ]. J Clin Oncol,1988, 6(10): 1562-9.
  • 6Hansen JA, Gooley TA, Martin PJ, et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia[J]. N Engl J Med, 1998, 338(10): 962-8.
  • 7Szydlo R, Goldman JM, Klein JP, et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings[J]. J Clin Oncol, 1997, 15(5): 1767-77.
  • 8黄河,林茂芳,孟海涛,钱文斌,黄健,金洁,蔡真,张洁,麦文渊,罗依,胡晓蓉,金爱云,陈水云,李政道,严力行.非亲缘异基因骨髓移植治疗急性和慢性白血病[J].中华医学杂志,2001,81(5):263-267. 被引量:17
  • 9许兰平,黄晓军,任汉云,张耀臣,郭乃榄,陆道培.非血缘关系异基因骨髓移植19例临床分析[J].中华内科杂志,2002,41(4):256-258. 被引量:12

共引文献16

同被引文献22

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部